To determine the prognostic values of HER-2 expression in bladder cancer, we recently analyzed the association between HER-2 expression and clinicopathological features in patients with non-muscle-invasive bladder cancer (NMIBC). This evidence concerns the gene ERBB2 and urinary bladder carcinoma.